363 related articles for article (PubMed ID: 37455827)
1. Capitalizing glycomic changes for improved biomarker-based cancer diagnostics.
Silva MLS
Explor Target Antitumor Ther; 2023; 4(3):366-395. PubMed ID: 37455827
[TBL] [Abstract][Full Text] [Related]
2. Aberrant glycosylation associated with enzymes as cancer biomarkers.
Meany DL; Chan DW
Clin Proteomics; 2011 Jun; 8(1):7. PubMed ID: 21906357
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
[TBL] [Abstract][Full Text] [Related]
4. Development of on-chip fully automated immunoassay system "μTASWako i30" to measure the changes in glycosylation profiles of alpha-fetoprotein in patients with hepatocellular carcinoma.
Kurosawa T; Watanabe M
Proteomics; 2016 Dec; 16(24):3056-3061. PubMed ID: 27272472
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.
Haga Y; Ueda K
Glycoconj J; 2022 Apr; 39(2):303-313. PubMed ID: 35156159
[TBL] [Abstract][Full Text] [Related]
6. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract][Full Text] [Related]
7. Semi-quantitative measurement of a specific glycoform using a DNA-tagged antibody and lectin affinity chromatography for glyco-biomarker development.
Lee JH; Cho CH; Kim SH; Kang JG; Yoo JS; Chang CL; Ko JH; Kim YS
Mol Cell Proteomics; 2015 Mar; 14(3):782-95. PubMed ID: 25525205
[TBL] [Abstract][Full Text] [Related]
8. Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.
Poon TC; Mok TS; Chan AT; Chan CM; Leong V; Tsui SH; Leung TW; Wong HT; Ho SK; Johnson PJ
Clin Chem; 2002 Jul; 48(7):1021-7. PubMed ID: 12089170
[TBL] [Abstract][Full Text] [Related]
9. Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma.
Edoo MIA; Chutturghoon VK; Wusu-Ansah GK; Zhu H; Zhen TY; Xie HY; Zheng SS
Iran J Public Health; 2019 Feb; 48(2):314-322. PubMed ID: 31205886
[TBL] [Abstract][Full Text] [Related]
10. Serum N-glycans outperform CA19-9 in diagnosis of extrahepatic cholangiocarcinoma.
Wang M; Fang M; Zhu J; Feng H; Warner E; Yi C; Ji J; Gu X; Gao C
Electrophoresis; 2017 Nov; 38(21):2749-2756. PubMed ID: 28752594
[TBL] [Abstract][Full Text] [Related]
11. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation markers in cancer.
Silsirivanit A
Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Pancreatic Ductal Adenocarcinoma-Related Aberrant Glycosylations: A Multilateral Approach of Lectin Microarray-Based Tissue Glycomic Profiling With Public Transcriptomic Datasets.
Wagatsuma T; Nagai-Okatani C; Matsuda A; Masugi Y; Imaoka M; Yamazaki K; Sakamoto M; Kuno A
Front Oncol; 2020; 10():338. PubMed ID: 32232009
[TBL] [Abstract][Full Text] [Related]
15. Glycoproteomic strategies: From discovery to clinical application of cancer carbohydrate biomarkers.
Ueda K
Proteomics Clin Appl; 2013 Oct; 7(9-10):607-17. PubMed ID: 23640819
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
Kirwan A; Utratna M; O'Dwyer ME; Joshi L; Kilcoyne M
Biomed Res Int; 2015; 2015():490531. PubMed ID: 26509158
[TBL] [Abstract][Full Text] [Related]
17. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
[TBL] [Abstract][Full Text] [Related]
18. Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.
Zhu J; Huang J; Zhang J; Chen Z; Lin Y; Grigorean G; Li L; Liu S; Singal AG; Parikh ND; Lubman DM
J Proteome Res; 2020 Aug; 19(8):3452-3466. PubMed ID: 32412768
[TBL] [Abstract][Full Text] [Related]
19. So You Discovered a Potential Glycan-Based Biomarker; Now What? We Developed a High-Throughput Method for Quantitative Clinical Glycan Biomarker Validation.
Shipman JT; Nguyen HT; Desaire H
ACS Omega; 2020 Mar; 5(12):6270-6276. PubMed ID: 32258861
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
